Our exclusively owned patent portfolio includes forty-five (45) issued patents, of which eleven (11) are U.S. patents and thirty-four (34) are foreign patents, with twenty-eight (28) of the thirty-four (34) foreign patents being nationally validated in certain European extension/validation states).

In addition, one U.S. patent application and seven foreign patent applications are pending.

The claims of these owned patents and patent applications are directed toward various aspects of our family of products, methods of their manufacturing, delivery device and research programs.